Skip to main content
Marvel Biosciences Corp. logo

Marvel Biosciences Corp. — Investor Relations & Filings

Ticker · MRVL ISIN · CA57384M1077 TSXV Professional, scientific and technical activities
Open in API
Filings indexed 203 across all filing types
Latest filing 2022-12-19 Regulatory Filings
Country CA Canada
Listing TSXV MRVL

About Marvel Biosciences Corp.

https://marvelbiotechnology.com/

Marvel Biosciences Corp. is a pre-clinical stage biotechnology company specializing in the discovery and development of transformative treatments for complex neurological and neurodevelopmental disorders, including Autism Spectrum Disorder, Rett Syndrome, and Fragile X Syndrome. The company's core strategy involves chemical innovation to create synthetic derivatives of existing approved molecules. This drug redevelopment approach leverages established mechanisms to accelerate development and reduce risk. Its lead candidate, MB-204, is a patented synthetic derivative that has demonstrated preclinical efficacy across these target indications and is currently advancing toward first-in-human studies.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification by the CFO of Marvel Biosciences Corp. regarding the interim financial report and interim MD&A for the period ended October 31, 2022. It is a Form 52-109FV2 Venture Issuer Basic Certificate, which is a certification of the interim filings rather than the filings themselves. The document does not contain actual financial data or substantive financial analysis but is an attestation of the accuracy and fair presentation of the interim filings. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report itself (IR). The document length is short (2959 characters), consistent with a certification letter rather than a full report.
2022-12-19 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate signed by the CEO. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended October 31, 2022. The document is primarily an officer certification letter and does not contain actual financial statements or substantive financial data. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is 3075 characters, which is relatively short and consistent with a certification letter rather than a full interim report.
2022-12-19 English
Interim MD&A - English.pdf
Management Reports Classification · 95% confidence The document is titled 'Management’s Discussion and Analysis' (MD&A) and dated December 19, 2022. It references unaudited condensed interim consolidated financial statements for the period ended October 31, 2022, and audited consolidated financial statements for the year ended July 31, 2022. The content includes detailed discussion of business strategy, product development, scientific progress, and forward-looking statements. The document length is about 15,000 characters, indicating a substantive report rather than a brief announcement. The MD&A is a management report explaining financial results, business trends, and outlook, which fits the definition of Management Reports (MDA). It is not an Annual Report (10-K) or Interim Report (IR) because it is specifically the MD&A section accompanying interim financials, and the text focuses on management's discussion rather than full financial statements. Therefore, the appropriate classification is Management Reports (MDA).
2022-12-19 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Interim Consolidated Financial Statements For the Three Months ended October 31, 2022 and 2021' and contains detailed unaudited financial statements including statements of financial position, loss and comprehensive loss, cash flows, and changes in shareholders' equity. It also includes notes to the financial statements and references compliance with IAS 34 'Interim Financial Reporting'. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. The presence of actual financial data and analysis for a period shorter than a full fiscal year confirms it is an interim or quarterly report. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2022-12-19 English
Material change report - English.pdf
Board/Management Information Classification · 95% confidence The document is a FORM 51-102F3 - MATERIAL CHANGE REPORT, which is a regulatory filing used to disclose material changes in a company. The content specifically announces changes in the company's Board of Directors, including the appointment of a new director and the resignation of another. The document is short (1433 characters) and focuses on management changes rather than financial data or detailed reports. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2022-11-24 English
News release - English.pdf
Board/Management Information Classification · 95% confidence The document is a press release announcing the appointment of a new director and the resignation of an existing director from the company's Board of Directors. It contains no financial data, no report or presentation, and no voting results. The content is focused on changes in the company's board members. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or regulatory filing. Hence, the classification is MANG with high confidence.
2022-11-24 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.